37
Pharma & HealthcareAvoid
LIC MF Healthcare
LIC · Direct–Growth · rank #14 of 19 by Smart Score
Data updated
Trailing returns
1 Year
15.8%
+17.9% vs index
3 Years
22.5%
+12.7% vs index
5 Years
12.8%
+3.3% vs index
Since launch
19.3%
Year-by-year performance
2024
+43.9%+28.3% vs index
2025
-3.2%-10.9% vs index
2026
+18.7%+22.4% vs index
Why this score
LIC MF Healthcare scores 37/100 — #14 of 19 Pharma & Healthcare fund (Avoid). It stands out for 3y return and sharpe ratio — beating 68% of peers on 3y return. The main drag is its 5y return (better than only 6% of peers).
Each bar shows the fund's percentile vs Pharma & Healthcare peers — a longer bar beats more of the category.
5Y return12.77% · 6th percentile in category
3Y return22.48% · 68th percentile in category
Fund size103.11 Cr · 8th percentile in category
Expense ratio1.42% · 14th percentile in category
Sharpe ratio1.12 · 72nd percentile in category
Volatility15.91 · 34th percentile in category
Top holdings
1.Sun Pharmaceutical Industries Ltd10.09%
2.Divi's Laboratories Ltd9.29%
3.Torrent Pharmaceuticals Ltd6.45%
4.Neuland Laboratories Ltd6.38%
5.Apollo Hospitals Enterprise Ltd6.23%
23 disclosed equity positions · portfolio as of Aug 2026 · weights are % of total corpus.